For research use only. Not for therapeutic Use.
PCSK9-IN-10(Cat No.:I042276)is a small molecule inhibitor targeting PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9), a protein involved in regulating cholesterol levels. By inhibiting PCSK9, PCSK9-IN-10 enhances the clearance of low-density lipoprotein cholesterol (LDL-C) from the bloodstream, potentially lowering cholesterol levels and reducing the risk of cardiovascular diseases such as heart attack and stroke. This compound is being investigated as part of ongoing research to develop novel treatments for hypercholesterolemia. PCSK9 inhibitors have gained attention as a promising therapeutic approach to managing cholesterol-related conditions.
Catalog Number | I042276 |
CAS Number | 368434-98-4 |
Synonyms | 8-(2-methoxyethylamino)-7-[(3-methoxyphenyl)methyl]-1,3-dimethylpurine-2,6-dione |
Molecular Formula | C18H23N5O4 |
Purity | ≥95% |
IUPAC Name | 8-(2-methoxyethylamino)-7-[(3-methoxyphenyl)methyl]-1,3-dimethylpurine-2,6-dione |
InChI | InChI=1S/C18H23N5O4/c1-21-15-14(16(24)22(2)18(21)25)23(17(20-15)19-8-9-26-3)11-12-6-5-7-13(10-12)27-4/h5-7,10H,8-9,11H2,1-4H3,(H,19,20) |
InChIKey | YUNMPASCLGGSKE-UHFFFAOYSA-N |
SMILES | CN1C2=C(C(=O)N(C1=O)C)N(C(=N2)NCCOC)CC3=CC(=CC=C3)OC |